Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes-Reference-Cited by-同舟云学术

Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes

Published:2016-08 Issue:4 Volume:68 Page:663-670
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Potęga Agnieszka,Fedejko-Kap Barbara,Mazerska Zofia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference35 articles.

1. 5-[(Aminoalkyl)amino]imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents Synthesis and biological activity;Cholody;J Med Chem,1990

2. Structure-activity relationship for antineoplastic imidazoacridinones: synthesis and antileukemic activity in vivo;Cholody;J Med Chem,1996

3. Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors;Skladanowski;Mol Pharmacol,1996

4. Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells;Skwarska;Biochem Pharmacol,2015

5. Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer;Burger;Br J Cancer,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Drug-Drug Interactions: A Systematic Review of the Cytochrome P450 (CYP) Isoenzyme 3A4;Research Journal of Pharmacy and Technology;2023-06-26

2. Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism and Cellular Response;International Journal of Molecular Sciences;2020-05-31

3. Cytochrome P450 Inhibition;Human Drug Metabolism;2020-02-21

4. Electrochemical simulation of metabolism for antitumor-active imidazoacridinone C-1311 and in silico prediction of drug metabolic reactions;Journal of Pharmaceutical and Biomedical Analysis;2019-05

5. Modulation of UDP-glucuronidation by acridinone antitumor agents C-1305 and C-1311 in HepG2 and HT29 cell lines, despite slight impact in noncellular systems;Pharmacological Reports;2018-06